← SynDRA
TALAMPANEL
SynDRA canonical compound SYN0002759 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | GRIA1 | GRIA2 | GRIA3 | GRIA4 |
| Mechanism of action | glutamate receptor antagonist |
All known targets
Mechanisms of action (all sources)
- GRIA2 ANTAGONIST
- Glutamate receptor ionotropic, AMPA 2 antagonist
- GRIA1 ANTAGONIST
- Glutamate receptor ionotropic, AMPA 1 antagonist
- glutamate receptor antagonist
Cross-references
Synonyms
- (-)-talampanel
- Ly300164
- GYKI-53773
- LY-300164
- Ampanel
- Kinampa
- IDR-53773
- Talampanel (INN)
- (8R)-7-acetyl-5-(4-aminophenyl)-8,9-dihydro-8-methyl-7H-1,3-dioxolo[4,5-h][2,3]benzodiazepine
- (R)-(-)-1-(4-Aminophenyl)-3-acetyl-4-methyl-7,8-methylenedioxy-3,4-dihydro-5H-2,3-benzodiazepine
- (R)-7-Acetyl-5-(p-aminophenyl)-8,9-dihydro-8-methyl-7H-1,3-dioxolo(4,5-h)(2,3)benzodiazepine
- (R)-7-acetyl-5-(p-aminophenyl)-8,9-dihydro-8-methyl-7H-1,3-dioxolo[4,5-h][2,3]benzodiazepine
- (-)-Talampanel
- LY 300164
- GYKI 53773
- LY300164
- CVS43XG1L5
- GYKI53773
- talampanelum
- RefChem:187215
- DTXCID7089750
- Talampanel [INN]
- Talampanel (GYKI 53773)
- GYKI-53773;LY-300164
- AC1L4UWP
- UNII-CVS43XG1L5
- MFCD00871406
- TALAMPANEL [MI]
- TALAMPANEL [USAN]
- SCHEMBL118011
- GTPL8279
- orb1307705
- SCHEMBL30272868
- Talampanel, >=97% (HPLC)
- CHEBI:34992
- JACAAXNEHGBPOQ-LLVKDONJSA-N
- GLXC-06006
- EX-A1569
Look up TALAMPANEL in the interactive SynDRA portal →